ESHELMAN FREDRIC N 4
4 · Aravive, Inc. · Filed Mar 31, 2022
Insider Transaction Report
Form 4
Aravive, Inc.ARAV
ESHELMAN FREDRIC N
Director
Transactions
- Award
Common Stock
2022-03-29$2.33/sh+860,216$2,000,002→ 4,666,314 total(indirect: See Footnote 1) - Award
Warrant (right to buy)
2022-03-29$2.20/sh+860,216$1,892,475→ 860,216 total(indirect: See footnote)Exercise: $2.20→ Common Stock (860,216 underlying)
Footnotes (2)
- [F1]The shares of common stock and Warrant to purchase shares of common stock of Aravive, Inc. (the "Company") are owned directly by Eshelman Ventures, LLC, an entity wholly owned by the Reporting Person. The Reporting Person, Dr. Fredric Eshelman, who is the Executive Chairman of the Company's Board of Directors, disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F2]The Warrant will be exercisable immediately and will expire on the five-year anniversary of the date of issuance; however, the Warrants will not be exercisable until the occurrence of certain events and will expire on the five- year anniversary of the date of exercisability.